News
Most automakers’ Q2 sales in the U.S. didn’t fare well, and of the three that did experience gains, one stood out ...
Live Updates Live Coverage Updates appear automatically as they are published. Still no earnings at 7:05 a.m. ET 7:04 am by ...
Discover Abbott Laboratories' Q2 2025 highlights: resilience drives high single-digit growth, double-digit EPS, and pipeline innovations.
Medical Devices achieved strong double-digit growth, while the Diagnostics segment in China saw ongoing pressure. These 10 stocks could mint the next wave of millionaires › Abbott Laboratories ...
Abbott (NYSE: ABT) shares dipped before hours today on second-quarter results that came in ahead of the consensus forecast.
Q2 2025 Results Conference Call July 17, 2025 9:00 AM ETCompany ParticipantsMichael Comilla - Vice President of ...
Abbott Laboratories(NYSE:ABT) reported its second-quarter 2025 results on July 17, 2025, posting 7.5% organic sales growth (excluding COVID testing), 12% medical device growth, and adjusted EPS of $1.
Abbott, a global healthcare leader, has reported strong results for its second quarter of 2025. According to the company's ...
Elon Musk's dream of having a top-selling electric pickup may be a thing of the past as the Cybertruck continues to see ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results